WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

RANDOMIZED CONTROL CLINICAL TRIAL OF A NOVEL COMPOUND DRUG MEDONASHAK VATI AND CHIRBILVA (HOLEPTELLIA INTREGRIFOLIA) KWATH IN THE MANAGEMENT OF MEDOROGA (OBESITY)

Acharya Balkrishan, Dr.Vijay kumar*, Pandey Awadhesh, Pathak Meenakshi S.N.

ABSTRACT

Nowadays obesity is a great problem in both developed and developing countries, affecting children as well as adults. Prevalence of obesity is increasing day by day due to alteration in eating habits, physical inactivity, emotional disturbances, increased alcohol consumption, smoking etc. Obesity is a major risk factor for many severe diseases like hypertension, diabetes mellitus, cardiovascular disorders, joint diseases, pulmonary diseases, endocrine disorders, cancer etc. Ayurveda deals with various dimensions of life and it is related to each and every living being present in the universe. Each and every activities of individual have been aimed to achieve sukha, by the right way of living. In Ayurvedic text eight types of body traits has been described. Atisthaulya is one of them, which deserves special attention, as it has been considered as a commonest risk factor for various disorders. To evaluate the efficacy and safety aspects of a Novel Ayurvedic regimen ie Medonashak vati and Chirbilva (Holeptellia intregrifolia) kwath in medoroga, a Randomized Control Clinical Trial was conducted in 50 patients of medoroga in Department of Swasthavritta, Patanjali Bharteeya Ayurvigyan Avum Anusandhan Sansthan, Haridwar, Uttarakhand. Assessment of efficacy was done by using a self designed proforma considering the the assessment of objective parameters such as Body mass index (BMI), Total Cholesterol, Triglycerides. High density lipid (HDL), Low density lipid (LDL) and Haemoglobin (Hb%) before and after the treatment. At the end of the treatment period, symptomatic improvement was found in the patients, statistically significant (p<0.001) reduction in the parameters was noticed. No side effects were reported by the patients over the treatment period.

Keywords: Atisthaulya, Chirbilva, Medonahsak vati, Medoroga,


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More